Please call Clinical Labs of Hawaii at 808.677.7998 (Option 1) with questions about this test.
Synonyms
Post Prostatectomy
PSA, Third Generation
Ultrasensitve PSA
PSA, Ultrasensitive
Collect
Serum Separator Tube (SST). Also acceptable: Green (lithium heparin), Lavender (K2EDTA, or Pink (K2EDTA).
Specimen Preparation
Allow specimen to clot completely at room temperature. Separate from cells ASAP or within 2 hours of collection. Transfer 1 mL serum or plasma to an ARUP Standard Transport Tube. (Min: 0.5 mL)
Stability (from collection to initiation)
After separation from cells: Ambient: 24 hours; Refrigerated: 5 days; Frozen: 6 months
Unacceptable Conditions
Grossly hemolyzed specimens. Vaginal washings.
Storage/Transport Temperature
Frozen.
Performed
Sun-Sat
Reported
Within 24 hours
Methodology
Quantitative Electrochemiluminescent Immunoassay
Test Site
ARUP (98581)
Reference Interval
0.00-4.00 ng/mL
Interpretive Data
After radical prostatectomy, the reference interval is less than 0.05 ng/mL if there is no residual disease. In healthy individuals without prostatectomy, the reference interval is 4.00 ng/mL or less. Lower limit of detection is 0.01 ng/mL.
The Roche PSA electrochemiluminescent immunoassay is used. Results obtained with different test methods or kits cannot be used interchangeably. The Roche PSA method is approved for use as an aid in the detection of prostate cancer when used in conjunction with a digital rectal exam in individuals with a prostate 50 years and older. The Roche PSA is also indicated for the serial measurement of PSA to aid in the prognosis and management of prostate cancer patients. Elevated PSA concentrations can only suggest the presence of prostate cancer until biopsy is performed. PSA concentrations can also be elevated in benign prostatic hyperplasia or inflammatory conditions of the prostate. PSA is generally not elevated in healthy individuals or individuals with nonprostatic carcinoma.
CPT Codes
84153
LOINC
35741-8
Collect
Serum Separator Tube (SST). Also acceptable: Green (lithium heparin), Lavender (K2EDTA, or Pink (K2EDTA).
Specimen Preparation
Allow specimen to clot completely at room temperature. Separate from cells ASAP or within 2 hours of collection. Transfer 1 mL serum or plasma to an ARUP Standard Transport Tube. (Min: 0.5 mL)
Storage/Transport Temperature
Frozen.
Stability (from collection to initiation)
After separation from cells: Ambient: 24 hours; Refrigerated: 5 days; Frozen: 6 months
Interpretive Data
After radical prostatectomy, the reference interval is less than 0.05 ng/mL if there is no residual disease. In healthy individuals without prostatectomy, the reference interval is 4.00 ng/mL or less. Lower limit of detection is 0.01 ng/mL.
The Roche PSA electrochemiluminescent immunoassay is used. Results obtained with different test methods or kits cannot be used interchangeably. The Roche PSA method is approved for use as an aid in the detection of prostate cancer when used in conjunction with a digital rectal exam in individuals with a prostate 50 years and older. The Roche PSA is also indicated for the serial measurement of PSA to aid in the prognosis and management of prostate cancer patients. Elevated PSA concentrations can only suggest the presence of prostate cancer until biopsy is performed. PSA concentrations can also be elevated in benign prostatic hyperplasia or inflammatory conditions of the prostate. PSA is generally not elevated in healthy individuals or individuals with nonprostatic carcinoma.
Please call Clinical Labs of Hawaii at 808.677.7998 (Option 1) with questions about this test.
Synonyms
Post Prostatectomy
PSA, Third Generation
Ultrasensitve PSA
PSA, Ultrasensitive
Collect
Serum Separator Tube (SST). Also acceptable: Green (lithium heparin), Lavender (K2EDTA, or Pink (K2EDTA).
Specimen Preparation
Allow specimen to clot completely at room temperature. Separate from cells ASAP or within 2 hours of collection. Transfer 1 mL serum or plasma to an ARUP Standard Transport Tube. (Min: 0.5 mL)
Stability (from collection to initiation)
After separation from cells: Ambient: 24 hours; Refrigerated: 5 days; Frozen: 6 months
Unacceptable Conditions
Grossly hemolyzed specimens. Vaginal washings.
Storage/Transport Temperature
Frozen.
Performed
Sun-Sat
Reported
Within 24 hours
Methodology
Quantitative Electrochemiluminescent Immunoassay
Test Site
ARUP (98581)
Reference Interval
0.00-4.00 ng/mL
Interpretive Data
After radical prostatectomy, the reference interval is less than 0.05 ng/mL if there is no residual disease. In healthy individuals without prostatectomy, the reference interval is 4.00 ng/mL or less. Lower limit of detection is 0.01 ng/mL.
The Roche PSA electrochemiluminescent immunoassay is used. Results obtained with different test methods or kits cannot be used interchangeably. The Roche PSA method is approved for use as an aid in the detection of prostate cancer when used in conjunction with a digital rectal exam in individuals with a prostate 50 years and older. The Roche PSA is also indicated for the serial measurement of PSA to aid in the prognosis and management of prostate cancer patients. Elevated PSA concentrations can only suggest the presence of prostate cancer until biopsy is performed. PSA concentrations can also be elevated in benign prostatic hyperplasia or inflammatory conditions of the prostate. PSA is generally not elevated in healthy individuals or individuals with nonprostatic carcinoma.
CPT Codes
84153
LOINC
35741-8
Collection
Collect
Serum Separator Tube (SST). Also acceptable: Green (lithium heparin), Lavender (K2EDTA, or Pink (K2EDTA).
Specimen Preparation
Allow specimen to clot completely at room temperature. Separate from cells ASAP or within 2 hours of collection. Transfer 1 mL serum or plasma to an ARUP Standard Transport Tube. (Min: 0.5 mL)
Storage/Transport Temperature
Frozen.
Stability (from collection to initiation)
After separation from cells: Ambient: 24 hours; Refrigerated: 5 days; Frozen: 6 months
Interpretive Data
After radical prostatectomy, the reference interval is less than 0.05 ng/mL if there is no residual disease. In healthy individuals without prostatectomy, the reference interval is 4.00 ng/mL or less. Lower limit of detection is 0.01 ng/mL.
The Roche PSA electrochemiluminescent immunoassay is used. Results obtained with different test methods or kits cannot be used interchangeably. The Roche PSA method is approved for use as an aid in the detection of prostate cancer when used in conjunction with a digital rectal exam in individuals with a prostate 50 years and older. The Roche PSA is also indicated for the serial measurement of PSA to aid in the prognosis and management of prostate cancer patients. Elevated PSA concentrations can only suggest the presence of prostate cancer until biopsy is performed. PSA concentrations can also be elevated in benign prostatic hyperplasia or inflammatory conditions of the prostate. PSA is generally not elevated in healthy individuals or individuals with nonprostatic carcinoma.
